T1	Intervention 349 454	Naltrexone, 1.0 mg/kg, was given daily in a randomized, double-blind, placebo-controlled crossover design
T2	Intervention 456 784	Dependent measures included parent and teacher Clinical Global Impressions (CGI), Conners Rating Scales, and Naltrexone Side-Effects (SE) Rating Scale; laboratory CGI, movement actometer readings, and a 10-second interval recording system analysis of on-task, communication initiations, disruptive behavior, and self-stimulation
